Non-Invasive Determination Of Methylome Of Tumor From Plasma

Patent No. EP4335929 (titled "Non-Invasive Determination Of Methylome Of Tumor From Plasma") was filed by The Chinese University OF Hong Kong on Sep 20, 2013. The application was issued on Jan 21, 2026.

Patent Summary

Plasma DNA methylation test that detects fetal or tumor DNA in maternal blood to avoid invasive procedures. The method sequences cell-free DNA and identifies specific methylation patterns to separate fetal or cancer DNA from the mother's background. It also checks for gene deletions or amplifications to confirm cancer presence. This approach allows non-invasive screening, monitoring, and prognosis without needing tissue biopsies.

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MAIWALD PATENTANWALTSOct 21, 2026MAIWALD PATENT- UND RECHTSANWALTSGESELLSCHAFT MBH
STRAWMANOct 21, 2026LEONARD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP4335929

THE CHINESE UNIVERSITY OF HONG KONG
Application Number
EP24153604A
Filing Date
Sep 20, 2013
Status
Granted And Under Opposition
Dec 19, 2025
Publication Date
Jan 21, 2026